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with Selective ActivityaKatherine A. Gibney, Iva Sovadinova, Analette I. Lopez, Michael Urban,
Zachary Ridgway, Gregory A. Caputo,* Kenichi Kuroda*We report the structure–activity relationship in the antimicrobial activity of linear and
branched poly(ethylene imine)s (L- and B-PEIs) with a range of molecular weights (MWs)
(500–12 000). Both L- and B-PEIs displayed enhanced activity against Staphylococcus aureus
over Escherichia coli. Both B- and L-PEIs did not cause any significant permeabilization of E. coli
cytoplasmic membrane. L-PEIs induced depolarization of S. aureus membrane although B-PEIs
did not. The low MW B-PEIs caused little or no hemolysis while L-PEIs are hemolytic. The
low MW B-PEIs are less cytotoxic to
human HEp-2 cells than other PEIs.
However, they induced significant cell
viability reduction after 24 h incubation.
The results presented here highlight
the interplay between polymer size
and structure on activity.1. Introduction
In recent years, antibiotic-resistant bacterial infections have
become a growing concern.[1–3] With the threat of traditional
antibiotics and antimicrobial agents becoming obsolete, the
development of new classes of antibiotics has become an
important subject of current research. Naturally occurringProf. K. Kuroda, K. A. Gibney
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 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim wileyonlinhost defense peptides have shown potential as alternatives
to the currently available antibiotics, but bioavailability
complications and the high cost of production have limited
their translation into the clinic. The cationic amphiphilic
structure of natural antibacterial peptides has been recog-
nized as the key properties of the peptide antibacterial
mechanism of action.[4–6] The cationic groups of peptides
facilitate the electrostatic binding of peptides to bacterial cell
surfaces with high net negative charge, which leads to the
selective attraction of the more negatively charged bacteria
over human cells. The amphiphilic structure of the peptides
drives the insertion of their hydrophobic side-chains into
the lipid membrane, which disrupts the membrane integ-
rity, causing leakage of cellular components, breakdown
of membrane potential, and cell death. These naturally
occurring amphiphilic biopolymers serve as models for the
design, behavior, and mechanism of action of synthetic,
cationic amphiphilic polymers.[7–9]
Traditional cationic poly(ethylene imine) polymers (PEIs)
have been utilized as drug carriers in biomedical applica-
tion because of their ability to enter cells or permeabilize
cell membranes.[10–13] Linear and branched PEIs (L-PEIs andelibrary.com DOI: 10.1002/mabi.201200052 1279
Figure 1. Cationic amphiphilic structures and schematic presentations of PEIs: (A) B-PEI and (B) L-PEI.
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K. Gibney et al.B-PEIs) (Figure 1) have shown potential as possible non-viral
vector systems for drug transport across cell mem-
branes.[14–16] In addition, a large number of studies have
focused on the antibacterial activity of water-soluble PEI
derivatives containing quaternized ammonium salt groups
with long alkyl or aromatic groups[17,18] and applications
for water-insoluble hydrophobic PEIs including nano-
particles,[19] and antibacterial coatings.[20,21] While the
properties of PEI derivatives have been extensively studied,
to the best of our knowledge, a systematic investigation of
the antimicrobial activity and cytotoxicity of conventional
unmodified PEIs is still limited.
The design strategy of modeling polymers on natural
cationic peptides has been projected onto numerous
synthetic polymers with cationic amphiphilic properties.
The protonated ammonium groups of the PEIs are cationic,
and the non-protonated amine groups and ethylene
backbone serve as hydrophobic groups, which create
repeating cationic amphiphilic structures along the poly-
mer backbone at neutral pH without any further chemical
modification by hydrophobic groups (Figure 1). Accord-
ingly, we hypothesized that unmodified PEI provided
the necessary cationic amphiphilic structures needed to
induce membrane disruption or permeabilization, leading
to antibacterial activity. To test this hypothesis, we
investigated a series of L-PEIs and B-PEIs, which differ in
their amine components as well as molecular weights,
for antibacterial activity and antimicrobial mechanism.
Herein, we report the structure–activity relationship for
antimicrobial activity as well as toxicity to human red
blood cells (RBCs hemolysis) and human epithelial carci-
noma HEp-2 cells for these PEI molecules. In addition, we
investigated the polymer-induced permeabilization of
bacterial cell membranes of Escherichia coli and Staphylo-
coccusaureus to gain insights into the mechanism of action.2. Experimental Section
2.1. Materials and General Methods
Branched PEIs (B-PEIs); MW¼600 (cat.: 02371, lot: 558322), 1 800
(cat.: 06089, lot: 559792), 10 000 (cat.: 19850, lot 579738), L-PEIs;
MW¼2 500 (cat.: 24313, lot: 587821), 25 000 (cat.: 23966, lot:Macromol. Biosci. 201
 2012 WILEY-VCH Verlag Gmb590965) were purchased from Polysciences, Inc. (Warrington, PA,
USA). 1H NMR and 13C NMR spectra were recorded in a Varian
MR400 NMR spectrometer at 400 and 100 MHz, respectively. See
Supporting Information for detailed procedures of gel permeation
chromatography (GPC), reverse-phase HPLC, dynamic light scatter-
ing, potentiometric titration, and biological assays.3. Results and Discussion
3.1. GPC Characterization
As an initial step in our investigation into the biological
activities of PEIs, we first characterized their molecular
structures and properties. We chose commercially available
PEIs because of their availability in a large quantities and
widespread use in a broad range of applications ranging
from biological transfection reagents to wet-strength resins
in the paper industry.[16,22,23] Despite the broad application
and plentiful availability of these molecules, these com-
mercially available preparations lacked thorough investi-
gation into both their chemical properties and, more
importantly, their potential as antimicrobial agents. In
order to fully understand any relationship between the
molecular composition, structural architecture, and anti-
microbial activity, an important benchmark was to
completely characterize the PEI molecule preparations for
testing. The molecular weight of polymers was determined
by GPC (Table 1 and Figure S1 of Supporting Information for
GPC elution curves). The PEIs are denoted as L/B-PEIx
(L: linear, B: branched, x: number-averaged molecular
weight determined by GPC in kDa). The B-PEIs used
in this study have a range of molecular weights
(Mn ¼ 470–12 000). While B-PEI0.5 has a broad MW dis-
tribution (Mw=Mn ¼ 4.5), the higher MW B-PEIs have
relatively low polydispersity (Mn=Mw < 1.6). Regarding
L-PEIs, the both L-PEIs have similar Mn, although the
MWs reported by a supplier have tenfold difference
(MW¼ 2 500 and 25 000), and the higher MW L-PEI6.5 has
a broader MW distribution. We used relatively low MW PEIs
in this study since high MW cationic polymers have been
shown to cause undesired cytotoxicity.[24,25] As such,
we expected that low MW PEIs were likely to be less
toxic while still exhibiting antibacterial behavior.2, 12, 1279–1289
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Table 1. Characterization of PEIs.
PEIsa) Polymer structure MWb) Mn (GPC) Mw (GPC) Mw=Mn RT [min]
c)
B-PEI0.5 Branched 600 470 2 100 4.5 –
d)
B-PEI1.1 Branched 1 800 1 100 1 400 1.3 7.0
B-PEI12 Branched 10 000 12 000 19 000 1.6 8.0
L-PEI4.4 Linear 2 500 4 400 7 900 1.8 7.9
L-PEI6.5 Linear 25 000 6 500 13 000 2.0 8.0
a)See the text for denotation; b)MW reported by a supplier; c)RT in reverse-phase HPLC; d)no distinctive peak was observed.
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1H and 13C NMR confirmed that B-PEIs contain primary,
secondary, and tertiary amine groups (Figure S2 and S3 of
Supporting Information). The NMR spectra showed dis-
tinctive peaks from protons and carbons of methylene
groups depending on adjacent different amine groups. The
peaks of the 13C NMR spectra appear to be sufficiently
separated for integration to determine the ratio of amine
groups. Integrated peaks of 13C NMR spectra of B-PEIs have
been used to determine the amine ratio of B-PEIs in
literature.[26,27] However, the 13C NMR spectra in Figure S3
of Supporting Information may not be sufficiently accurate
for comparing integrated areas because the data acquisi-
tion and NMR parameters were not optimized. Quantitative
analysis would require more time-intensive data acquisi-
tion and further optimization of NMR parameters, which
would be beyond the scope of this study. Therefore, we
carried out deconvolution analysis of overlapped peaks in
the 1H NMR spectra (Supporting Information) to estimate
the ratio of amine groups (Table 2). Although the ratios of
different amines do not exactly match the theoretical ratio
(primary, secondary, and tertiary amine groups¼ 25/50/
25% of each group per chain), the similar trend was found.
The ratio of secondary amines (linear chain) to tertiary
amines (branching point) increased as the PEI molecularTable 2. Amine ratio and apparent pKa of B-PEIs.
PEIs Amine [%] pKa1a) pKa2a)
1- 2- 3- 2-/3-
B-PEI0.5 33 42 24 1.75 9.4 6.2
B-PEI1.1 25 46 29 1.58 9.6 6.2
B-PEI12 28 40 32 1.25 9.0 5.8
Ethanolamine 100 – – – 9.8 –
a)pKa is reported as the pH to give the maximum buffer capacity.
The pKa value is an average from two experiments. The range of
two data points was smaller than 4% relative to the average values
(Supporting Information).
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MWs have more branching structures.
On the other hand, the 1H NMR spectra of L-PEIs showed a
single peak from the ethyleneimine unit with secondary
amines,[28] indicating a linear polymer structure (Figure S2
of Supporting Information). The spectra also showed peaks
from residual N-propionyl groups (Figure 2),[28,29] and
analysis of integrated areas indicated that L-PEI4.4 and
L-PEI6.5 contain 10.6 and 3.8 mol% of N-propionyl groups
relative to the total number of repeating units, respectively
(Supporting Information). In general, L-PEIs are synthesized
by ring-opening isomerization polymerization of 2-ethyl-2-
oxazoline (Figure 2) and the subsequent acid hydrolysis to
remove N-propionyl groups. The removal of N-propionyl
groups was evidently not complete for these commercially
available L-PEIs.3.3. Potentiometric Titration
To assess the cationic functionality of the PEIs, their
ionization behavior was examined by acid titration
(Figure 3). All the B-PEIs tested in this study (oily liquid)
are completely miscible with water or saline (150 mm
NaCl). The titration curves showed multiple shoulders,
indicating the different buffer effects depending on the
amine structures (Figure 3A). To examine the buffer effect of
B-PEIs, their buffer capacity [b¼ dc(HCl)/dpH, where c(HCl)
is added HCl concentration], was approximated by the
inverse slope of the adjacent two data points in the titration
curves. The plots showed two peaks around pH 9–10 and
6–7 (Figure 3B), indicating that the B-PEIs have buffer H
N
N
O
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Figure 2. Chemical structure of L-PEIs: (A) 2-ethyl-2-oxazoline and
(B) L-PEI with N-propionyl groups.
2, 12, 1279–1289
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Figure 3. Potentiometric titration of B-PEIs: (A) representative
pH titration curves and (B) buffer capacity.
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distinctive, likely corresponding to primary/secondary
amines with strong basicity, and the latter is due to
tertiary amines.[16,26,30] The apparent pKa was determined
as the pH value to give the peak top value of b (Table 2). As a
control, the pKa of ethanolamine was 9.8, which is in close
agreement with the value (9.5) reported in literature.[31]
Because the pKa1 is greater than 9, most primary and
secondary amine groups are protonated under the assay
conditions of pH 7. The pKa2 values for all B-PEIs are around
6–6.4, suggesting that a large fraction of tertiary amine
groups are not protonated at pH 7. Combining the results of
NMR analysis, approximately 72, 71, and 68 mol% of total
amine groups of B-PEI0.5, B-PEI1.1, and B-PEI12 are cationic at
the assay pH, respectively. On the other hand, L-PEIs are not
readily soluble in water at mg mL1 concentrations and
caused turbidity in solution during titration. Therefore,
titration curves and buffer capacities could not be deter-
mined; otherwise, the analysis would not be quantitative.3.4. Reverse-phase HPLC
To further assess the amphiphilic properties of PEIs, the
hydrophobicity of PEIs was examined by reverse-phaseMacromol. Biosci. 201
 2012 WILEY-VCH Verlag GmbHPLC (Figure S5 of Supporting Information). The retention
time (RT) measured by HPLC reflects the inherent hydro-
phobicity of the polymers at low pH where all amines are
presumably protonated. The overall hydrophobicity of PEIs
would therefore be dependent on the degree of protonation
of amine groups and may be different under neutral pH
assay conditions. Nonetheless, differences in RTs are a good
gauge of inherent hydrophobicity differences under the
same set of sample conditions. The RT of B-PEI12 (7.7 min) is
greater than that of B-PEI1.1 (7.0 min) (Table 1), indicating
B-PEI12 is somewhat more hydrophobic than B-PEI1.1. The
greater relative hydrophobicity of B-PEI12 corroborates the
low basicity found in the titration, that is, the molecule has
a greater fraction of uncharged groups at the neutral pH
or lower pKa value than other B-PEIs. The hydrophobic
environment of B-PEI12 likely disfavors the protonation of
amine groups, contributing to factors for the lower pKa
value of B-PEI12 (Table 2). Combining with the titration
results, this indicates that the B-PEIs have cationic
amphiphilic structures in water. Both L-PEIs showed similar
RT of 8.0 min at low pH where L-PEIs are soluble
although L-PEI4.4 showed a broader peak in the elution
curve compared to others.3.5. Antimicrobial Activity
To examine the antimicrobial activities of these PEIs, we
measured the minimum inhibitory concentration (MIC),
which is the minimum polymer concentration necessary
for completely inhibiting bacterial growth under standard
assay conditions (Table 3). The B-PEIs are completely
miscible with water; however, the L-PEIs are not readily
soluble in water at mg mL1 concentrations. Instead, the
L-PEIs were found to be readily soluble in ethanol. Therefore,
different procedures were used when preparing the B-PEI
and L-PEI solutions for biological assays. The L-PEIs were
first dissolved in ethanol and serially diluted twofold with
0.01% acetic acid to give assay stock solutions with a range
of polymer concentrations while B-PEI stock solutions were
prepared by only tris-buffered saline (TBS, 10 mM Tris
buffer, 150 mM NaCl, pH¼ 7.3). These stock solutions were
mixed with bacterial solution in Mueller-Hinton (MH) broth
for MIC determination. The highest ethanol concentration
in the assay solution was 5%, and the control experiments
using solvents (TBS, 0.01% acetic acid, and acetic acid/
ethanol mixtures) showed no difference in the bacterial
growth after the 18-h incubation as determined by the
turbidity or OD600.
Among the B-PEIs examined, B-PEI1.1 displayed the
lowest MIC value (250mg mL1) against E. coli (Gram-
negative), while B-PEI12 displayed no activity (MIC>
1 000mg mL1), indicating that increasing MW does not
enhance antibacterial activity. For comparison, the MIC of
the natural antimicrobial peptide magainin 2 (MW¼ 2 300)2, 12, 1279–1289
H & Co. KGaA, Weinheim www.MaterialsViews.com
Table 3. Antimicrobial and hemolytic activities of PEIs and peptides.
Polymers MIC [mg mL1] MICE. c./MICS. a.a) HC50
[mg mL1]b)
HC50/MIC
E. c. S. a. E. c. S. a.
B-PEI0.5 500 16 32 >4 000 (1%)
c) >4 >64
B-PEI1.1 250 32 8 >4 000 (2%)
c) >8 >256
B-PEI12 >1 000 16 >64 >4 000 (2%)
c) – 128
L-PEI4.4 31 8 4 565 104 18 37
L-PEI6.5 31 8 4 163 23 6 12
Magainin-2 125d) >500d) <0.3 >250 (9%)c),d) >2 –
Melittin 13d) 6d) 2 2d) 0.1 0.2 0.3
a)The ratio of MIC for E. coli (E. c.) to MIC for S. aureus (S. a.); b)polymer concentration for 50% hemolysis. The presented data and error are
average and standard deviation from at least three independent experiments in triplicate; c)the hemolysis percentage at the highest
polymer concentration is given if the HC50 was not determined;
d)the data were previously reported.[56]
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titration results indicated that B-PEI12 has 68 mol% of
cationic ammonium groups, slightly lower than other
B-PEIs, and the RP-HPLC results showed the intrinsic
hydrophobicity of B-PEI12 is higher than B-PEI1.1. Although
it has been previously reported that increasing the
hydrophobicity of cationic amphiphilic PEIs[18] and poly-
(propylene imine) dendrimers,[32,33] increases their anti-
microbial activity, PEI12 showed lower activity against
E. coli as compared to other PEIs. On the other hand, both
L-PEIs exhibited MIC values of 31mg mL1 against E. coli
possibly due to the similar molecular weight (Mn ¼ 4 400
and 6 500). Additionally, the MICs for the L-PEIs are eight
times lower than those for the most active B-PEI1.1
(MIC¼ 250mg mL1), suggesting that the L-PEIs are more
effective at inhibiting E. coli growth.
It has been reported that the excess hydrophobicity of
B-PEIs quaternized with long alkyl groups decreases their
antibacterial activity because the formation of aggregates
is likely to reduce the number of polymer chains available to
interact with bacterial cell membranes.[18] Dynamic light
scattering showed that the unmodified B- and L-PEIs
studied here showed little or no light scattering over the
concentration range of MICs in phosphate buffer solution
or the assay medium (MH broth) compared to a sample
containing a suspension of polystyrene nanoparticles of
known, standard size (Figure S5 in Supporting Information).
This indicates that the B- and L-PEIs do not form any
significant or measurable aggregates under the assay
conditions. This result implies that the polymers are not
‘‘trapped’’ in an aggregated form that could reduce the
ability to interact with the bacterial cell membranes,
decreasing their efficacy. Compared to hydrophobically
modified PEIs, the hydrophilic nature of unmodified B-PEIswww.MaterialsViews.com
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polymer chains against bacterial cells.
When tested for activity against the Gram-positive
bacteria S. aureus, the MICs of B-PEIs were 16–31mg mL1
while magainin-2 did not display potent activity against
the same strain (MIC> 250mg mL1). The MIC values are
orders of magnitude smaller than those for E. coli (Table 3).
Although B-PEI12 did not display potent activity against
E. coli (MIC> 1 000mg mL1), the MIC value for S. aureus is
16mg mL1, yielding a MIC selectivity index MIC (E. coli)/
MIC (S. aureus) of >64 (Table 3). Other B-PEIs also showed
the MIC selectivity index larger than 8. These results
indicate that the B-PEIs are selectively active against
S. aureus over E. coli. Similarly, both L-PEIs also had an MIC
value of 8mg mL1 against S. aureus, which is fourfold
lower than that for E. coli (Table 3). This suggests that the
L-BEIs are also selective to S. aureus over E. coli (the MIC
selective index¼ 4).
It has been reported that the identity of counter anions
for ammonium groups of synthetic polymers and dendri-
mers can affect antibacterial activity, although the
mechanism is not clear yet.[33–35] Although there is no
information on the presence or identity of counter anions in
the commercially available PEIs studied here, counter
anions, if present, may also affect the antibacterial activity
of PEIs. Determination of the effect of counter ions on their
antibacterial activity would be of interest for further
investigation to modulate PEI antibacterial activity.3.6. E. coli Membrane Permeabilization
As many natural cationic-amphiphilic peptides exhibit the
ability to disrupt lipid bilayers, we assessed the ability of
the PEIs to permeabilize bacterial membranes to gain2, 12, 1279–1289
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Figure 4. E. coli OM leakage. Absorbance was measured at
486 nm. (A) L-PEI2.5 kinetics. (B) Endpoint absorbance after
90min for L-PEIs. (C) Endpoint absorbance after 90min for B-PEIs.
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molecules. The periplasmic protein b-lactamase and the
colorimetric substrate nitrocefin are used as reporters for
changes in the permeability of the outer membrane (OM) of
E. coli.[36–38] Under normal conditions, the cephalosporin
analog nitrocefin cannot easily diffuse across the E. coli OM
and therefore shows a low degree of conversion into the
chromophore product. Once the PEIs (or other compounds)
permeabilize the OM, the nitrocefin can diffuse into the
periplasm and the b-lactamase can cleave the substrate,
yielding a compound with absorbance at 486 nm. Since
this assay monitors the enzymatic reaction, the rate of
chromophoric product formation (rate of increase in
absorbance) is related to the ability of the nitrocefin to
cross the OM which can be altered by the interaction of the
PEIs with the membrane.
Figure 4A shows typical kinetic curves of the production
of the nitrocefin cleavage product in cells exposed to L-PEI6.5.
This membrane permeabilizing activity of the L-PEIs was
shown to be dose-dependent (Figure 4B). The samples
treated with L-PEIs exhibited increasing amounts of
chromophore production at low polymer concentrations,
followed by a plateau above 6mg mL1 (Figure 4B). Both
L-PEI4.4 and L-PEI6.5 showed similar concentration depen-
dence even though they have different MWs. On the other
hand, the B-PEIs displayed much lower levels of chromo-
phore production compared to L-PEIs (Figure 4C), which
mirrors the lower activity of B-PEIs against E. coli compared
to L-PEIs.
The experimental design to test the integrity of the inner
membrane is similar to that for the OM except that the
cytoplasmic enzyme b-galactosidase and the chromogenic
substrate ONPG are used as the reporter for the assay. The
results of this assay showed very little, if any, permeabiliza-
tion of the inner membrane of the E. coli upon exposure to
the B-PEIs or L-PEIs tested even though the L-PEIs displayed
significant permeabilization of the E. coli OM (Figure S6 in
Supporting Information). Although, we hypothesized that
the cationic amphiphilic structures of PEIs may exert
antibacterial effects by disrupting bacterial cell membranes
similar to natural antibacterial peptides, this result
indicates that molecular mechanisms other than the
disruption of the E. coli inner membrane may factor in
the activity. It has been reported that some cationic
antimicrobial peptides are translocated though the IM
without significant disruption and subsequently bind to
cytoplasmic enzymes and DNA/RNA, inhibiting macro-
molecular synthesis.[39–41] It has also been reported that
B-PEI with a MW of 50 kDa strongly permeabilized the OMs
of Gram-negative bacteria, but the PEI did not significantly
inhibit the bacterial growth.[42] However, Tashiro reported
bactericidal activity of B-PEI with MW of 600 on E. coli at
the concentrations of 25–100mg mL1 in saline.[43,44]
We found that the B-PEI12 are not active against E. coliMacromol. Biosci. 201
 2012 WILEY-VCH Verlag Gmb(MIC> 1 000mg mL1) in MH broth and do not significantly
permeabilize the OM of E. coli. However, the lower MW
B-PEIs displayed relatively weak inhibitory effects against
E. coli (MIC¼ 250–500mg mL1) although they are also not
strong membrane permeabilizers. The low MW B-PEIs could
have better ability to penetrate the cell wall structure
without becoming trapped in the anionic peptidoglycan
layers and liposaccharides (LPA) because of the lower
density of cationic charges on the PEI surfaces due to smaller
molecular size.3.7. S. aureus Membrane Permeabilization
Considering that the PEIs show selective activity against
S. aureus over E. coli, the permeabilizing ability of PEIs
was also tested against S. aureus. The single membrane2, 12, 1279–1289
H & Co. KGaA, Weinheim www.MaterialsViews.com
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www.mbs-journal.dearchitecture of this Gram-positive bacteria allows for the
direct interrogation of bilayer integrity by assaying
the membrane potential using the potential-sensitive
fluorophore DiSC3(5).[45–50] This compound is a membrane
potential-sensitive dye that accumulates in the S. aureus
membrane and undergoes self-quenching when the
membrane is intact. Upon depolarization of the membrane
(in this case caused by PEIs), the self-quenching is alleviated
and thus the fluorescence emission from DiSC3(5) increases.
Therefore, an increase in the fluorescence emission
intensity indicates the ability of PEIs to disrupt the
S. aureus cell membrane.
As a control, both L-PEIs and B-PEIs did not show any
significant fluorescence intensity changes when mixed
with the fluorophore in the absence of bacteria (Supporting
Information). The B-PEIs displayed little or no effect on
the membrane depolarization up to concentrations of five
times the MIC (Figure 5 and Supporting Information). The
lytic peptide melittin at its MIC induced rapid increase in
fluorescence intensity, suggesting that the peptide per-
meabilizes the cytoplasmic membrane of S. aureus. Inter-
estingly, addition of melittin to the assay solutions at 200 s
did not cause any significant fluorescence change even
though complete membrane depolarization was expected.
This result suggests that the melittin action against
S. aureus cell membranes was inhibited. To investigate
this inhibitory effect, melittin and B-PEIs were mixed prior
to addition to S. aureus suspension. Under these conditions,
melittin did not appear to induce membrane depolarization
(Supporting Information). These results indicate that the0
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Figure 5. S. aureus membrane depolarization by PEIs and melittin
in HEPES buffer. A membrane potential-sensitive DiSC3(5) dye in
ethanol was added to S. aureus suspension at 20 s. After the
fluorescence intensity was leveled due to dye uptake by S. aureus,
PEI or melittin was added to the suspension to give final con-
centrations equal to their MICs as determined in MH broth
(Table 1). At 200 s, melittin was added to the assay solution
containing PEIs.
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formation between melittin and PEIs.
Epand et al. reported that an acyl-Lys oligomer is selective
toward S. aureus over E. coli.[46] The oligomer is bacterio-
static and did not exhibit a strong permeabilization ability
against the S. aureus membrane and that the oligomer did
not interact with DNA, which supports the hypothesis that
the oligomer does not interact with cytoplasmic targets.
The authors propose that the acyl-Lys oligomers bound to
cell wall block extracellular nutrients, resulting in starva-
tion. In addition, Raafat et al. reported that the cationic
property of the polysaccharide chitosan is a key factor in
the antibacterial activity against S. aureus.[51] The authors
speculate that chitosan binds to anionic biopolymer
teichoic acids in the cell wall, which causes a sequence of
‘‘untargeted’’ molecular events including membrane depo-
larization, resulting in bacterial cell death. These reports
suggest that the B-PEIs may also exhibit multiple
targets and steps in the antibacterial mechanism against
S. aureus. It has also been reported that cationic poly-
norbornene derivatives display selective activity to
S. aureus over E. coli.[52,53] The authors proposed that the
double membrane structure of the E. coil cell wall, which
controls the polymer’s transit to the cytoplasmic mem-
brane, is responsible for the selective activity toward E. coli
over S. aureus.[52] Although these mechanisms proposed in
literature may be also at work with PEIs, the antimicrobial
mechanism of PEIs against S.aureus is not clear at this point.
In contrast, the L-PEIs exhibited the ability to disrupt the
S. aureus membrane potential, where the membrane
disruption induced by L-PEI6.5 is comparable to the lytic
peptide melittin (Figure 5). The L-PEIs may exert an
antibacterial effect against S. aureus, at least in part, by
membrane disruption, which could reflect the higher
activity (lower MIC values) against S. aureus compared to
the B-PEIs tested in this study.3.8. Hemolysis
In order for a compound to be a viable antibiotic, it must be
relativity non-toxic to human cells by selectively targeting
bacterial cells. To assess the cytotoxicity of the polymers to
human cells, we first determined the hemolytic activity of
PEIs. The release of hemoglobin molecules from lysis of
human RBCs in the presence of the PEIs was monitored by
absorbance spectroscopy. In general, the RBC membrane
surfaces are less negatively charged than the bacterial cell
surface. When cationic amphiphilic polymers are exten-
sively hydrophobic, they can non-selectively bind to the
RBCs and cause cell lysis.[54,55] In this assay, hemolysis
reflects damage to human cell membranes induced by PEIs.
The HC50 value for each polymer (the concentration
necessary for 50% hemolysis) was determined from the
dose-hemolysis curves (Figure 6). Lysis of all RBCs (100%2, 12, 1279–1289
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Figure 6. Hemolysis induced by PEIs. Each data point represents
the average of three independent experiments in triplicate
standard deviation.
Figure 7. PEI-induced LDH release from HEp-2 cells. Each data
point represents the average of three independent experiments
in triplicate standard deviation. Lines are present to guide the
eye and do not represent a mathematical fit of the data.
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surfactant Triton-X.
The B-PEIs showed little (less than 5%) or no hemolytic
activity up to 2 000mg mL1 (Figure 6) although they
displayed antibacterial activity within this concentration
range (Table 1). For instance, B-PEI1.8 displayed antibacterial
activity against E. coli (MIC¼ 250mg mL1) and S. aureus
(MIC¼ 31mg mL1), giving HC50/MIC selectivity indices of
>8 for E. coli and >256 for S. aureus. These results indicate
that the B-PEIs are selective agents for bacteria over RBCs.
For comparison, the lytic peptide melittin displayed an HC50
of 2mg mL1 under the same assay conditions and a
corresponding selectivity index of 0.2–0.3.
On the other hand, both L-PEIs caused greater than
60% hemolysis at a polymer concentration of
1 000mg mL1. L-PEI6.5 displayed higher hemolytic activity
(HC50¼ 195mg mL1) compared to L-PEI4.4 (HC50¼
577mg mL1), indicating the higher MW PEIs are more
hemolytic although the antimicrobial activity of these
L-PEIs was same. Although the L-PEIs caused appreciable
hemolysis, their HC50 values are orders of magnitudes
higher than the MIC values; the selectivity index of L-PEI4.4
is 18 for E. coli and 32 for S. aureus. This suggests that the
L-PEIs are also selective to bacteria over RBCs.
The result of antibacterial assays showed that the PEIs
exhibit selectively enhanced activity against S. aureus over
E. coil (Table 3). Based on the hemolysis results, the activity of
PEIs is also selective to the tested bacteria over human RBCs,
indicating the PEIs have desirable cell-selectivity. It has been
also reported that cationic polynorbornene derivatives
displayed similar selectivity against S. aureus over E. coli
and RBCs, which was referred as ‘‘double selectivity’’.[52] An
acyl-Lys oligomer also showed selective toward S. aureus
over E. coli.[46] These indicate that the cationic and
amphiphilic properties of polymers or oligomers may be
the determining factor for their cell-selective antibacterial
activity rather than the polymer molecular structures.Macromol. Biosci. 201
 2012 WILEY-VCH Verlag Gmb3.9. Lactate Dehydrogenase (LDH) Assay
We further evaluated the effect of PEIs on human HEp-2
cells, isolated from larynx epidermoid carcinoma with HeLa
markers, as a gauge of PEI-induced cytotoxicity to human
cells as well as to tumor cells. We first examined cell
membrane integrity of HEp-2 cells in the presence of these
polymers. We measured the amount of LDH that leaks from
cells human HEp-2 cells after exposure to the PEIs. This LDH
assay reports the damage of membrane damage caused by
the polymers in general (Figure 7 and Table 2). In contrast to
the hemolysis assay using RBCs, HEp-2 cells are metabo-
lically active cells, therefore the LDH assay reports the effect
of PEIs on the membrane of actively proliferating cells.
B-PEI0.5 and B-PEI1.1 caused little or no LDH leakage
(Figure 7). Interestingly, B-PEI12 caused LDH release in as low
as 4mg mL1, and the LDH release leveled off above
250mg mL1, giving 30% release (Figure 8) although
B-PEI12 was not hemolytic (Figure 4). In the same assay,
melittin caused significant LDH release, giving EC50 (peptide
concentration for 50% LDH release) of 1.5mg mL1 although
magainin displayed only little effect (9%) up to 250mg mL1.
Fischer et al. reported that B-PEI with MW 600–1000 kDa
caused 30–80% LDH release after 1 h from L929 mouse
fibroblasts in the PEI concentration range from 0.01 to
1 mg mL1 for 60 min.[24] Hong et al. also demonstrated
that B-PEI with an MW of 78 220 induced significant LDH
release from human KB cells (oral carcinoma origin) after
3 h, and rat Rt2 cells (derived from glioma). These results
suggest that while the cells are tolerant to low MW PEIs,
high MW PEIs are potentially toxic to many different
types of the mammalian cells by compromising the
cell membrane structure. On the other hand, L-PEI6.5 and
L-PEI4.4 caused 27 and 10% LDH leakage at 250mg mL1,
respectively, as both L-PEIs caused membrane damage to
RBCs (hemolysis). Similar to the B-PEIs, the low MW L-PEIs
are also less toxic.2, 12, 1279–1289
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Figure 8. Cell viability after exposure to PEIs for (A) 1 h and (B) 24 h.
Each data point represents the average of three independent
experiments in triplicate standard deviation.
Figure 9. Cell viability after 1 h (open box) and 24 h (shaded box)
exposure time to PEIs. Each data point represents the average
of three independent experiments in triplicate standard
deviation.
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The XTT assay reports the inhibition of metabolic activity of
cells (Table 4), providing information on cell viability in the
presence of polymers that is not directly tied to membrane
permeability. All PEIs displayed concentration- and mole-
cular weight- dependent effects on the viability of HEp-2
cells after 1 h exposure (Figure 8). B-PEI12 displayed highestTable 4. Cytotoxicity of PEIs to human epithelial HEp2 cells.
PEI or peptide EC50
[mg mL1]a)
B-PEI0.5 >4 000 (4%)
d)
B-PEI1.1 >4 000 (6%)
d)
B-PEI12 >4 000 (30%)
d)
L-PEI4.4 >250 (8%)
d)
L-PEI6.5 >250 (27%)
d)
Magainin-2 >250 (3%)d)
Melittin 1.5 0.1
a)PEI concentration for 50% LDH release in an LDH assay. The da
triplicate standard deviation; b)PEI concentration for 50% viability in
experiments in triplicate standard deviation; c)incubation time of c
percentage at the highest polymer concentration was given if the EC
www.MaterialsViews.com
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 2012 WILEY-VCH Verlag Gmbtoxic effect on cell viability; the viability reduced to 80% in
the presence of 10mg mL1 of B-PEI12, and no viable cells
were observed at 1 000mg mL1, giving IC50 value of
26mg mL1, which is the polymer concentration necessary
for 50% inhibition of metabolic activity of cells (Table 4),
B-PEIs with lower MWs (B-PEI0.5 and B-PEI1.1) only reduced
the cell viability at high polymer concentrations, although
they did not display LDH release.
Similarly, the L-PEIs also reduced cell viability as
the polymer concentration increased. As the molecular
weights of L-PEIs were increased from 4 400 to 6 500,
the corresponding IC50 values decreased from 153 to
70mg mL1 (Figure 9 and Table 4). Considering that theIC50 [mg mL1]b)
1 hc) 24hc)
>4 000 (73%)d) 2 305 225
1 026 90 116 16
27 3 7 0.4
155 15 13 0.9
69 9 8 0.4
>250 (94%)d) >250 (100%)d)
1.3 0.1 1.4 0.1
ta represent the average of three independent experiments in
an XTT assay. The data represent the average of three independent
ells with PEIs in the XTT assay; d)the LDH leakage or cell viability
50 or IC50 was not determined.
2, 12, 1279–1289
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be partially responsible for the cell viability reduction.
We further examined the effect of longer time exposure
to PEIs (24 h) on the viability of HEp-2 cells (Figure 8B).
In this experiment, the transitions in the viability curves
are shifted toward the lower PEI concentrations, indicating
the PEIs are more toxic to the cells after longer exposure
time. The IC50 values of PEIs decreased by an order of
magnitude after 24-h exposure (Figure 9 and Table 4). L-PEIs
and B-PEI10 showed an IC50 of 10mg mL1, which
is the lowest IC50 value of this PEI series. These results
suggest that the use of these PEIs needs to be limited
to short term topical treatment rather than systemic
administration for long-term infection treatment.4. Conclusion
In conclusion, we investigated a series of B-PEIs and L-PEIs
with relatively low MWs to study the effect of molecular
architecture and size on antibacterial activity. The activity
against E. coli and S. aureus depended on both the PEI
architecture and MW. Interestingly, the PEIs displayed
selective activity against S. aureus over E. coli. The
membrane permeabilization assays suggested that PEIs
may exert their antibacterial activity by mechanisms other
than membrane disruption, contrary to our original
hypothesis. The PEIs are also selective to bacteria over
RBCs, indicating the antimicrobial action of unmodified
PEIs is cell-selective. The combined results of two indepen-
dent cytotoxic assays (LDH release assay and XTT assay)
show that the low MW B-PEIs are less cytotoxic to human
HEp-2 cells than their linear counterparts. However, even
these polymers significantly reduced cell viability after a
24 h exposure time.
The results presented here will be useful in optimizing
the antibacterial activity and cytotoxicity of PEIs as well as
in studying the antimicrobial mechanisms of these and
similar cationic amphiphilic macromolecules. Although
PEIs quaternized with alkyl groups have been extensively
studied as membrane-active antibacterials, understanding
the intrinsic antimicrobial mechanisms of unmodified PEIs
is advantageous to designing antibacterial agents for
optimal activity and cell selectivity. Synthetic polymers
such PEIs are not cost or labor intensive to produce, and well
established methods in polymer chemistry enables acces-
sible modifications of their chemical and physical proper-
ties, which will facilitate their further development as new
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